secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phio Pharmaceuticals Corp. (PHIO)
CIK:        0001533040
Form:       8-K
Filed at:   2022-05-02T23:59:59+00:00
Accession:  0001683168-22-003069
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phio appoints Patricia A. Bradford to board; amends bylaws on director count
----------------------------------------------------------------------------

- Board size increased to eight; Patricia A. Bradford appointed effective April 27, 2022.
- Bradford is former SVP Global HR at Unisys; not assigned to any board committee initially.
- Bylaws amended to let board fix director number by resolution; previously capped at seven.
- Bradford will receive standard non-employee director compensation and indemnification.
- No material transactions or arrangements with Bradford or family per Item 404(a).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533040/000168316822003069/0001683168-22-003069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533040/000168316822003069/phio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-003069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer